Teresa Bellón

Dr. Teresa Bellón

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 August 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
RPRen-You Pan
Ren-You Pan
MCMu-Tzu Chu
Mu-Tzu Chu
CWChuang-Wei Wang
Chuang-Wei Wang
YLYun-Shien Lee
Yun-Shien Lee
FLFrancois Lemonnier
Francois Lemonnier
Shuen-Iu HungShuen-Iu Hung
Shuen-Iu Hung
Drug hypersensitivity such as severe cutaneous adverse reactions (SCAR), including Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), could be life-threatening. Here, we enroll SCAR patients to investigate the T cell receptor (TCR) repertoire by next-generation sequencing. A public αβTCR is identified from the cytotoxic T lymphocytes of patients with carbamazepine-SJS/TEN, with its expression showing drug/phenotype-specificity and an bias for HLA-B*15:02. This public αβTCR has binding affinity for carbamazepine and its structural analogs, thereby mediating the immune response. Adoptive transfer of T cell expressing this public αβTCR toHLA-B*15:02transgenic mice receiving oral administration of carbamazepine induces multi-organ injuries and symptoms mimicking SCAR, including hair loss, erythema, increase of inflammatory lymphocytes in the skin and blood, and liver and kidney dysfunction. Our results not only demonstrate an essential role of TCR in the immune synapse mediating SCAR, but also implicate potential clinical applications and development of therapeutics.

24 April 2019 in Drug Safety
Verified
Journal Article
Closed access
PDF file
TBTeresa Bellón
Teresa Bellón

19 December 2017 in Clinical & Experimental Allergy
Verified
Journal Article
Closed access
PDF file
RCR. Cabañas
R. Cabañas
OCO. Calderón
O. Calderón
Elena RamírezElena Ramírez
Elena Ramírez
AFA. Fiandor
A. Fiandor
TCT. Caballero
T. Caballero
TBTeresa Bellón
Teresa Bellón

27 April 2014 in Transplantation
Verified
Journal Article
Closed access
MLMaría Ovidia López-Oliva
María Ovidia López-Oliva
VMVirginia Martinez
Virginia Martinez
ÁBÁgueda Buitrago
Águeda Buitrago
CJCarlos Jiménez
Carlos Jiménez
BRBegoña Rivas
Begoña Rivas
TBTeresa Bellón
Teresa Bellón
Background Cytomegalovirus (CMV) infection is an ongoing clinical problem in solid-organ transplantation (SOT). Pretransplant CMV serology is currently the only tool for assessing the risk of CMV infection, although cellular immune responses driven by CMV-specific CD4 and CD8 T lymphocytes are important for controlling viral replication. Therefore, the analysis of CMV-specific T cells may be useful for estimating the risk of infection. Methods This is a prospective study of patients with kidney transplants and no prophylactic treatment for CMV replication. CD4 and CD8 T-cell responses to the major CMV pp65 and IE-1 antigens in 15 seropositive patients at intermediate risk of CMV infection were investigated, according to current algorithms. Intracellular flow cytometry was employed to determine IFN-γ production as a functional readout. The response was analyzed in pretransplant samples and prospectively at 1 and 6 months and at 1 year posttransplant. Results It was observed that the CD8 responses to IE-1 antigen were practically absent pretransplant in patients who developed CMV infection posttransplant. Within the group of patients free of infection, CD8 responses to IE-1 were detected more frequently and were significantly higher (P=0.0083). In a receiver operating characteristics curve analysis (AUC=0.929; P=0.010; 95% CI: 0.078–1.0), low CD8 responses to IE-1 (≤0.05%) pretransplant predicted the development of CMV infection under the immunosuppressive regime after transplant with 100% specificity and 85.7% sensitivity. Conclusions Assessment of IE-1-specific CD8 T-cell frequencies pretransplant may be a useful tool for identifying seropositive SOT patients at risk of developing CMV infection posttransplant.

1 March 2016 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
TBTeresa Bellón
Teresa Bellón
VLV. Lerma
V. Lerma
OGO. González-Valle
O. González-Valle
CHC. González Herrada
C. González Herrada
Francisco J. De AbajoFrancisco J. De Abajo
Francisco J. De Abajo

26 September 2019 in Allergy
Verified
Journal Article
Closed access
PDF file
TBTeresa Bellón
Teresa Bellón
SRSara Rodríguez-Martín
Sara Rodríguez-Martín
RCRosario Cabañas
Rosario Cabañas
ERElena Ramírez
Elena Ramírez
VLVictoria Lerma
Victoria Lerma
TGthe PIELenRed study group
the PIELenRed study group